3 most recent filings and news items mentioning AVXL. Updated every 60 seconds.
curl "https://api.brieftape.com/v1/tickers/AVXL/news?limit=20"
Pull AVXL filings straight into your trading bot, model, or app.
Get an API key — free tier: 10,000 calls/dayAnavex Life Sciences nominated two new independent directors and filed a preliminary proxy statement to reject takeover attempts by PVG Asset Management and Patrick Adams while establishing an Executive Committee led by Dr. Jiong Ma.
View filing at SEC.gov →Anavex Life Sciences filed an IND for ANAVEX2-73 targeting early Alzheimer's disease. The company implemented a disciplined data-driven strategy focusing on FDA engagement.
View filing at SEC.gov →Anavex Life Sciences received a delinquency notification from Nasdaq on May 20, 2026, due to failure to timely file its Form 10-Q for Q2 2026, and has until July 20, 2026 to submit a compliance plan. The notification has no immediate effect on the company's stock listing but sign
View filing at SEC.gov →